138 related articles for article (PubMed ID: 37434993)
1. Seroprevalence of SARS-CoV-2 immunoglobulin G in HIV-positive and HIV-negative individuals in KwaZulu-Natal, South Africa.
Francois KA; Msomi N; Govender K; Gounder L; Moodley P; Parboosing R; Chetty I; Xaba L; Khan A
Afr J Lab Med; 2023; 12(1):2065. PubMed ID: 37434993
[TBL] [Abstract][Full Text] [Related]
2. Similar Antibody Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Individuals Living Without and With Human Immunodeficiency Virus on Antiretroviral Therapy During the First South African Infection Wave.
Snyman J; Hwa SH; Krause R; Muema D; Reddy T; Ganga Y; Karim F; Leslie A; Sigal A; Ndung'u T;
Clin Infect Dis; 2022 Aug; 75(1):e249-e256. PubMed ID: 34472583
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021.
Sykes W; Mhlanga L; Swanevelder R; Glatt TN; Grebe E; Coleman C; Pieterson N; Cable R; Welte A; van den Berg K; Vermeulen M
Res Sq; 2021 Feb; ():. PubMed ID: 33594353
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 After the Second Wave in South Africa in Human Immunodeficiency Virus-Infected and Uninfected Persons: A Cross-Sectional Household Survey.
Wolter N; Tempia S; von Gottberg A; Bhiman JN; Walaza S; Kleynhans J; Moyes J; Buys A; McMorrow ML; Aitken S; Magni S; Yun J; Fellows T; Maakamedi T; Weiner R; Cawood C; Martinson N; Lebina L; Jassat W; Brauer M; Cohen C
Clin Infect Dis; 2022 Aug; 75(1):e57-e68. PubMed ID: 35271693
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.
Spinelli MA; Lynch KL; Yun C; Glidden DV; Peluso MJ; Henrich TJ; Gandhi M; Brown LB
Lancet HIV; 2021 Jun; 8(6):e334-e341. PubMed ID: 33933189
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa.
Sawry S; Le Roux J; Wolter N; Mbatha P; Bhiman J; Balkus J; von Gottberg A; Cohen C; Chersich M; Kekana M; Ndlovu T; Shipalana A; Mthimunye W; Patel F; Gous H; Walaza S; Tempia S; Rees H; Fairlie L
Int J Infect Dis; 2022 Dec; 125():241-249. PubMed ID: 36347458
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020.
Manolea C; Capitanescu A; Borș R; Rugescu I; Bechir M; Mehedintu C; Varlas V
Hum Reprod Open; 2021; 2021(3):hoab028. PubMed ID: 34322605
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of HIV infection in rural South Africa.
Abdool Karim Q; Abdool Karim SS; Singh B; Short R; Ngxongo S
AIDS; 1992 Dec; 6(12):1535-9. PubMed ID: 1492937
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
[TBL] [Abstract][Full Text] [Related]
10. IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.
Kaddu-Mulindwa D; Keuser L; Lesan V; Rissland J; Smola S; Werdecker V; Stilgenbauer S; Christofyllakis K; Thurner L; Bewarder M; Lohr B; Lutz J; Lohse S; Rieke A
HIV Med; 2022 May; 23(5):564-569. PubMed ID: 34811869
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
13. Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence.
Miller CN; Althoff KN; Schlueter DJ; Anton-Culver H; Chen Q; Garbett S; Ratsimbazafy F; Thomsen I; Karlson EW; Cicek M; Pinto LA; Malin BA; Ohno-Machado L; Williams C; Goldstein D; Kouame A; Ramirez A; Gebo KA; Schully SD;
mSphere; 2022 Oct; 7(5):e0025722. PubMed ID: 36173112
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19).
Kislaya I; Gonçalves P; Gómez V; Gaio V; Roquette R; Barreto M; Sousa-Uva M; Torres AR; Santos J; Matos R; Manita C; Almeida Santos J; Soeiro S; de Sousa R; Costa I; Verdasca N; Guiomar R; Rodrigues AP;
Infect Dis (Lond); 2022 Jun; 54(6):418-424. PubMed ID: 35023439
[TBL] [Abstract][Full Text] [Related]
15. The seroprevalence of COVID-19 in patients living with HIV in metropolitan Detroit.
Gudipati S; Lee M; Scott M; Yaphe S; Huisting J; Yared N; Brar I; Markowitz N
Int J STD AIDS; 2022 May; 33(6):554-558. PubMed ID: 35333100
[TBL] [Abstract][Full Text] [Related]
16. The SARS-COV-2 Seroprevalence among Oncology Patients.
Kgatle M; Das R; Lawal I; Boshomane T; Mokoala K; Gaspar C; Mbokazi L; Nkambule N; Gow V; Ndlovu H; Mzizi Y; Chalwe J; Diphofa J; Mokobodi D; Gxekwa N; Zongo L; Maphosa T; Vorster M; Bassa S; Venkatesan A; Khanyile R; Munga Y; Ebenhan T; Zeevaart JR; Sathekge M
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675457
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 lateral flow IgG seropositivity and serum neutralising antibody responses after primary and booster vaccinations in Chile: a cross-sectional study.
Sauré D; O'Ryan M; Torres JP; Zuñiga M; Soto-Rifo R; Valiente-Echeverría F; Gaete-Argel A; Neira I; Saavedra V; Acevedo ML; Archila C; Acuña F; Rain M; Basso LJ
Lancet Microbe; 2023 Mar; 4(3):e149-e158. PubMed ID: 36716754
[TBL] [Abstract][Full Text] [Related]
18. Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic.
O'Kelly B; McLaughlin R; O'Doherty R; Carroll H; Murray R; Dilworth R; Corkery L; Cotter AG; McGinty T; Muldoon EG; Cullen W; Avramovic G; Sheehan G; Sadlier D; Higgins M; O'Gorman P; Doran P; Inzitari R; Holden S; O'Meara Y; Ennis S; Lambert JS
Front Med (Lausanne); 2021; 8():642318. PubMed ID: 34513853
[No Abstract] [Full Text] [Related]
19. National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic.
Palmateer NE; Dickson E; Furrie E; Godber I; Goldberg DJ; Gousias P; Jarvis L; Mathie L; Mavin S; McMenamin J; McNeilly TN; Murcia P; Murray J; Reid G; Robertson C; Templeton K; von Wissmann B; Wallace LA; Waugh C; McAuley A
Public Health; 2021 Sep; 198():102-105. PubMed ID: 34411992
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among HIV Infected Individuals Attending ART Centre at Pune: A Cross-Sectional Study.
Ghate M; Shidhaye P; Gurav S; Gadhe K; Kale V; Jain P; Thakar M
J Int Assoc Provid AIDS Care; 2022; 21():23259582221077943. PubMed ID: 35128977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
